Last reviewed · How we verify

Dry Ice (CARBON DIOXIDE)

FDA-approved active Small molecule Quality 15/100

Dry Ice, also known as solid carbon dioxide, is a radiographic contrast agent used in medical imaging. It works by providing contrast in X-ray images, allowing for better visualization of internal structures. However, as it is not a pharmaceutical drug, it does not have a specific target or mechanism of action. Dry Ice is not a patented or generic pharmaceutical, but rather a naturally occurring substance. It is not approved by the FDA for medical use, but is commonly used in medical settings for imaging purposes.

At a glance

Generic nameCARBON DIOXIDE
Drug classRadiographic Contrast Agent [EPC]
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: